Evidence map›Paper›PMID 35448152›Full record

ArticleCurrent oncology (Toronto, Ont.)2022

Basosquamous Basal Cell Carcinoma with Bone Marrow Metastasis.

Lise Mayrin Økland Thunestvedt, Lars Helgeland, Ingeborg Margrethe Bachmann, Åsa Karlsdottir, Torjan Magne Haslerud, Håkon Reikvam

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Current oncology (Toronto, Ont.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lise Mayrin Økland ThunestvedtDepartment of Medicine, Haukeland University Hospital, 5021 Bergen, Norway.
Lars HelgelandInstitute of Medical Science, University of Bergen, 5007 Bergen, Norway.
Ingeborg Margrethe BachmannInstitute of Medical Science, University of Bergen, 5007 Bergen, Norway.
Åsa KarlsdottirDepartment of Oncology, Haukeland University Hospital, 5021 Bergen, Norway.
Torjan Magne HaslerudDepartment of Radiology and Nuclear Medicine, Haukeland University Hospital, 5021 Bergen, Norway.
Håkon ReikvamDepartment of Medicine, Haukeland University Hospital, 5021 Bergen, Norway.ORCID 0000-0001-5439-8411

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Basal cell carcinoma (BCC) is the most common cancer in Caucasians. It is slow growing and rarely metastasizes. If left untreated over time, invasive growth can occur. We present a patient case with a primary BCC located in the right sub-mammary area, with extensive metastases to the skeleton and bone marrow. Histopathological examination of the tumour showed BCC with a diverse growth pattern. There were no signs of local metastases. Surgery was successfully performed. Three months post-surgery the patient developed normocytic anaemia and elevated inflammation markers. [

Indexed as

Basal Cell CarcinomaBone Marrow NeoplasmsBone NeoplasmsSkin NeoplasmsFluorodeoxyglucose F18HumansPositron Emission Tomography Computed TomographyFluorodeoxyglucose F18basal cell carcinomabone marrow invasionbone marrow metastasisnonmelanoma skin cancer

Identifiers

PMID35448152
PMCPMC9031135

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.